TY - JOUR
T1 - Pathology of Pancreatic Cancer Precursor Lesions
AU - Noë, Michaël
AU - Brosens, Lodewijk A A
N1 - Copyright © 2016 Elsevier Inc. All rights reserved.
PY - 2016/12
Y1 - 2016/12
N2 - To better understand pancreatic ductal adenocarcinoma (PDAC) and improve its prognosis, it is essential to understand its origins. This article describes the pathology of the 3 well-established pancreatic cancer precursor lesions: pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and mucinous cystic neoplasm. Each of these precursor lesions has unique clinical findings, gross and microscopic features, and molecular aberrations. This article focuses on histopathologic diagnostic criteria and reporting guidelines. The genetics of these lesions are briefly discussed. Early detection and adequate treatment of pancreatic cancer precursor lesions has the potential to prevent pancreatic cancer and improve the prognosis of PDAC.
AB - To better understand pancreatic ductal adenocarcinoma (PDAC) and improve its prognosis, it is essential to understand its origins. This article describes the pathology of the 3 well-established pancreatic cancer precursor lesions: pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and mucinous cystic neoplasm. Each of these precursor lesions has unique clinical findings, gross and microscopic features, and molecular aberrations. This article focuses on histopathologic diagnostic criteria and reporting guidelines. The genetics of these lesions are briefly discussed. Early detection and adequate treatment of pancreatic cancer precursor lesions has the potential to prevent pancreatic cancer and improve the prognosis of PDAC.
U2 - 10.1016/j.path.2016.05.004
DO - 10.1016/j.path.2016.05.004
M3 - Article
C2 - 27926360
SN - 1875-9181
VL - 9
SP - 561
EP - 580
JO - Surgical Pathology Clinics
JF - Surgical Pathology Clinics
IS - 4
ER -